New York TimesUPDATE 2-Express Scripts drops Gilead hep C drugs for cheaper AbbVie rivalReuters(Adds broader impact on biotechnology stocks). By Caroline Humer. Dec 22 (Reuters) - The largest U.S. pharmacy benefit manager said on Monday it has lined up a cheaper price for AbbVie Inc's newly approved hepatitis C treatment and, in most cases, will ...Express Scripts turns to AbbVie in huge hepatitis C dealThe Seattle TimesAbbVie lowers price of hepatitis C drug to win deal with Express ScriptsChicago TribuneGilead slides after hepatitis drug setbackFinancial TimesBusinessweek -Forbes -Philly.comall 217 news articles »